–
Тезисы докладов
-
- 2022 Alofanib in subsequent therapy of advanced gastric cancer: Final results from the phase Ib clinical trialL
- Vladimirova L.Y., Kurakin V., Besova N., Statsenko G., Mochalova A., Trenina N., Artamonova E., Novoselova K., Titova T., Abramova N.A., Obarevich E., Kashanova A., Suetina M., Agranov I., Iugai S., Raskin G., Kazey V., Rykov I., Tjulandin S., Tsimafeyeu I.
- в сборнике Annals of Oncology (2022), серия Suppl 1, том 33, тезисы, с. 45P
-
- 2021 Preliminary data on a phase 1b, first-in-human study of the allosteric extracellular FGFR2 inhibitor alofanib in patients with refractory metastatic gastric cancer
- Tsimafeyeu Ilya, Statsenko Galina, Mochalova Anastasia, Trenina Natalia, Kurakin Vyacheslav, Besova Natalia, Novoselova Kristina, Abramova Natalia, Obarevich Ekaterina, Kashanova Alina, Suetina Margarita, Moiseyenko Vladimir, Byakhov Mikhail, Artamonova Elena, Vladimirova Liubov, Tjulandin Sergei
- в сборнике Proceedings of the American Association for Cancer Research Annual Meeting 2021;, серия 13, том 82, тезисы, с. 113